<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02643342</url>
  </required_header>
  <id_info>
    <org_study_id>HSEARS20150909002</org_study_id>
    <nct_id>NCT02643342</nct_id>
  </id_info>
  <brief_title>A 2-year Longitudinal Study on the Structural and Optical Effects of Orthokeratology Treatment on Eye</brief_title>
  <official_title>A 2-year Longitudinal Study on the Structural and Optical Effects of Orthokeratology Treatment on Eye</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Hong Kong Polytechnic University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Menicon Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Queensland University of Technology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Aston University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The Hong Kong Polytechnic University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a two-year longitudinal study investigating the optical and structural effects of
      increased compression factor of orthokeratology lens on eyes and the corresponding effect on
      change in choroidal thickness and therefore myopic control.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">June 18, 2016</start_date>
  <completion_date type="Anticipated">March 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Axial length</measure>
    <time_frame>every 6 monthly in 2 years</time_frame>
    <description>axial progression of the eyeball</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ocular aberration measured by Complete Ophthalmic Analysis System (COAS) aberrometer</measure>
    <time_frame>every 6 monthly in 2 years</time_frame>
    <description>ocular aberration measured by Complete Ophthalmic Analysis System (COAS) aberrometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Corneal biomechanics (corneal response using ocular response)</measure>
    <time_frame>every 6 monthly in 2 years</time_frame>
    <description>corneal response using ocular response</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Accommodation lag measured by Complete Ophthalmic Analysis System (COAS) aberrometer</measure>
    <time_frame>every 6 monthly in 2 years</time_frame>
    <description>accommodation lag measured by Complete Ophthalmic Analysis System (COAS) aberrometer using different accommodation targets</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Choroidal thickness captured by Optical Coherent Tomographer (OCT)</measure>
    <time_frame>every 6 monthly in 2 years</time_frame>
    <description>choroidal thickness captured by Optical Coherent Tomographer (OCT) and measured using a customized software</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Myopic Progression</condition>
  <arm_group>
    <arm_group_label>Single-vision glasses</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Subjects wearing single-vision glasses CR-39 of refractive index 1.56.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Orthokeratology with normal compression factor</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Subjects wearing orthokeratology lenses of normal compression factor about 0.50-0.75D.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Orthokeratology with increased compression factor</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects wearing orthokeratology lenses of increased compression factor about 1.50-1.75D.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Orthokeratology</intervention_name>
    <arm_group_label>Orthokeratology with increased compression factor</arm_group_label>
    <arm_group_label>Orthokeratology with normal compression factor</arm_group_label>
    <other_name>ortho-k</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  6 to 10 years old

          -  Myopia: between 0.50 D and 4.00 D in both eyes

          -  Astigmatism: &lt;1.50 D; ≤ 1.25 D for with-the-rule astigmatism (axes 180 ± 30); ≤ 0.50 D
             for astigmatism of other axes in both eyes

          -  Anisometropia: ≤ 1.50 D

          -  Symmetrical corneal topography with corneal toricity &lt;2.00 D in both eyes

          -  Agree for randomization

        Exclusion Criteria:

          -  Contraindications for orthokeratology wear (e.g. limbus-to-limbus corneal cylinder and
             dislocated corneal apex)

          -  Any type of strabismus or amblyopia

          -  Myopic treatment (e.g. refractive surgery and progressive lens wear for myopic
             control) before and during the study period

          -  Rigid contact lenses (including orthokeratology lenses) experience

          -  Systemic condition which might affect refractive development (for example, Down
             syndrome, Marfan's syndrome)

          -  Ocular conditions which might affect the refractive error (for example, cataract,
             ptosis)

          -  Poor compliance for lens wear or follow-up
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pauline Cho, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Hong Kong Polytechnic University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>School of Optometry, The Hong KOng Polytechnic University</name>
      <address>
        <city>Hong Kong</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Lam CS, Lam CH, Cheng SC, Chan LY. Prevalence of myopia among Hong Kong Chinese schoolchildren: changes over two decades. Ophthalmic Physiol Opt. 2012 Jan;32(1):17-24. doi: 10.1111/j.1475-1313.2011.00886.x.</citation>
    <PMID>22150587</PMID>
  </reference>
  <reference>
    <citation>Cho P, Cheung SW, Edwards M. The longitudinal orthokeratology research in children (LORIC) in Hong Kong: a pilot study on refractive changes and myopic control. Curr Eye Res. 2005 Jan;30(1):71-80.</citation>
    <PMID>15875367</PMID>
  </reference>
  <reference>
    <citation>Cho P, Cheung SW. Retardation of myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial. Invest Ophthalmol Vis Sci. 2012 Oct 11;53(11):7077-85. doi: 10.1167/iovs.12-10565.</citation>
    <PMID>22969068</PMID>
  </reference>
  <reference>
    <citation>Chen C, Cheung SW, Cho P. Myopia control using toric orthokeratology (TO-SEE study). Invest Ophthalmol Vis Sci. 2013 Oct 3;54(10):6510-7. doi: 10.1167/iovs.13-12527.</citation>
    <PMID>24003088</PMID>
  </reference>
  <reference>
    <citation>González-Méijome JM, Villa-Collar C, Queirós A, Jorge J, Parafita MA. Pilot study on the influence of corneal biomechanical properties over the short term in response to corneal refractive therapy for myopia. Cornea. 2008 May;27(4):421-6. doi: 10.1097/ICO.0b013e318164e49d.</citation>
    <PMID>18434845</PMID>
  </reference>
  <reference>
    <citation>Wolffsohn JS, Safeen S, Shah S, Laiquzzaman M. Changes of corneal biomechanics with keratoconus. Cornea. 2012 Aug;31(8):849-54. doi: 10.1097/ICO.0b013e318243e42d.</citation>
    <PMID>22495031</PMID>
  </reference>
  <reference>
    <citation>Tse DY, Lam CS, Guggenheim JA, Lam C, Li KK, Liu Q, To CH. Simultaneous defocus integration during refractive development. Invest Ophthalmol Vis Sci. 2007 Dec;48(12):5352-9.</citation>
    <PMID>18055781</PMID>
  </reference>
  <reference>
    <citation>Chan B, Cho P, Mountford J. The validity of the Jessen formula in overnight orthokeratology: a retrospective study. Ophthalmic Physiol Opt. 2008 May;28(3):265-8. doi: 10.1111/j.1475-1313.2008.00545.x.</citation>
    <PMID>18426426</PMID>
  </reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>December 28, 2015</study_first_submitted>
  <study_first_submitted_qc>December 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 31, 2015</study_first_posted>
  <last_update_submitted>February 29, 2020</last_update_submitted>
  <last_update_submitted_qc>February 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Hong Kong Polytechnic University</investigator_affiliation>
    <investigator_full_name>Pauline Cho</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>myopia control</keyword>
  <keyword>orthokeratology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease Progression</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

